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Background: Plasmodium parasites typically elicit a non-sterile but protective immune response in human host
populations, suggesting that the parasites actively modulate normal immunological mechanisms. P-selectin is a
cell surface receptor expressed in mammals, that is a known component of the inflammatory response against
pathogens and has been previously identified as a host factor that influences malaria-associated pathology both in
human patients and rodent infection models.
Methods: To better understand the molecular mechanisms underlying the involvement of P-selectin in the
pathogenesis of malaria, a systematic extracellular protein interaction screen was used to identify Plasmodium
falciparum merozoite surface protein 7 (MSP7) as a binding partner of human P-selectin. This interaction, and
those occurring between P-selectin and Plasmodium MSP7 homologues, was characterized biochemically.
Results: Plasmodium falciparum MSP7 and P-selectin were shown to bind each other directly via the N-terminus
of PfMSP7 and the P-selectin C-type lectin and EGF-like domains. Orthologous proteins in the murine parasite
Plasmodium berghei (PbMSRP1 and PbMSRP2) and mouse P-selectin also interacted. Finally, P-selectin, when
complexed with MSP7, could no longer bind to its endogenous carbohydrate ligand, Sialyl-LewisX.
Conclusions: Novel interactions were identified between Plasmodium MSP7 protein family members and host
P-selectin receptors. Since PfMSP7 could prevent interactions between P-selectin and its leukocyte ligands, these
results provide a possible mechanism for the known immunomodulatory effects of both MSP7 and P-selectin in
malaria infection models.
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Malaria is among the world’s most devastating and wide-
spread infectious diseases and represents a significant bar-
rier to socio-economic development in the world’s poorest
countries [1–3]. The deadliest form of malaria is caused
by the parasite Plasmodium falciparum and the clinical
symptoms are associated with the blood stages of infection
when merozoite-stage parasites invade, multiply within
and then destroy host erythrocytes. The most severe out-
come is cerebral malaria that leads to high mortality and
can cause permanent brain injury to surviving patients.
Plasmodium parasites have evolved effective immunoreg-
ulatory mechanisms so that sterile immunity develops* Correspondence: gw2@sanger.ac.uk
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transmission [4]. Consequently, there is a pressing need
for novel therapeutics, particularly a vaccine, the rational
design of which will be greatly aided by a deeper under-
standing of the molecular mechanisms by which host and
pathogen interact.
Extracellular host and pathogen factors are at the nexus
of host-parasite interactions and often mechanistically ex-
plain and determine the pathological outcome of infec-
tion. P-selectin (SELP, also known as CD62P) is a host cell
surface receptor protein that is known to influence
malaria-associated pathology, both in human patients and
rodent infection models [5–8]. P-selectin is required for
the efficient recruitment of circulating leukocytes to sites
of localized inflammation, being rapidly up-regulated on
the surface of inflamed vascular endothelial cells [9, 10].icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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tetrasaccharides displayed on leukocyte cell surface glyco-
proteins, particularly PSGL-1 (P-Selectin Glycoprotein Lig-
and 1) [11]. Patients deficient in P-selectin function suffer
from persistent bacterial infections, demonstrating the im-
portance of this protein in regulating the response to infec-
tion in humans [12]. There is also increasing evidence that
P-selectin plays an important role in Plasmodium infec-
tions. In humans, there is evidence that increased levels of
a secreted form of P-selectin are found in patients present-
ing with non-severe versus severe malaria [5], possibly
by out-competing and reducing interactions between
membrane-tethered endothelial P-selectin and the parasite
ligand PfEMP1, which is displayed on the surface of in-
fected erythrocytes [8, 13]. Consistent with this, P-selectin
accumulates in the brains of mouse strains that are suscep-
tible to experimental cerebral malaria (ECM), but not in re-
sistant strains [6]; also, ECM-susceptible mouse strains that
are P-selectin-deficient do not succumb to cerebral path-
ology [6]. Together, these data suggest that P-selectin-
mediated inflammatory responses contribute to the path-
ology of severe cerebral malaria; however, because blood
cell sequestration does not appear to be altered in the
brains of P-selectin-deficient mice, the mechanism by
which P-selectin appears to exacerbate severe disease is still
unexplained and could be distinct from its known adhesive
roles [7].
A systematic protein interaction screening method
(AVEXIS, for AVidity-based EXtracellular Interaction
Screen) that is specifically designed to identify extracellular
protein interactions was used to further investigate the
mechanistic basis of P-selectin function in the pathogenesis
of malaria. Using a highly avid P-selectin binding regent and
a panel of P. falciparum merozoite proteins, a direct inter-
action between P-selectin and merozoite surface protein 7
(MSP7) was identified. Plasmodium falciparumMSP7 forms
part of the abundant MSP1 complex on the surface of mer-
ozoites and the phenotypes of MSP7-deficient parasites sug-
gest that this protein plays an important, but non-essential,
role in erythrocyte invasion [14–16].
In this work, the interaction between P-selectin and
PfMSP7 was characterized biochemically and it was
shown that P-selectin function was impaired in the pres-
ence of PfMSP7 because it could no longer interact with
its endogenous glycan ligand Sialyl-LewisX. Interactions
between P-selectin and the wider MSP7 protein family
could, therefore, play an immunomodulatory role, separ-
ate from PfMSP7’s role in erythrocyte invasion, during
Plasmodium infections.
Methods
Expression and purification of recombinant proteins
The plasmids encoding the entire ectodomains of 17 P.
falciparum merozoite proteins and human P-selectin weredescribed previously [17–19]; the ectodomain of mouse P-
selectin was amplified from a plasmid encoding a full-
length cDNA (Origene, NM_011347.1). Regions encoding
sub-regions or defined domains of PfMSP7 and P-selectin
were amplified by PCR from plasmids encoding the entire
ectodomain and cloned into appropriate expression plas-
mids. Boundaries for each of the recombinant P-selectin
protein fragments were as follows: M1ANC…IQEA771 (1),
M1ANC…CEAI570 (2), M1ANC…EAIS385 (3), M1ANC…
EYVR208 (4), M1ANC…YTAS162 (5), Y159TAS…IQEA208
(6), where amino acid numbers pertain to P16109 in
Uniprot and correspond to those in Fig. 4a. Similarly,
the PfMSP7 fragments shown in Fig. 4b are delineated
by the following boundaries: T1PVN…LNTM351 (PfM
SP7), T1PVN…VKAQ176 (PfMSP7-N), S177ETD…LN
TM351 (PfMSP722), E195VQK…LNTM351 (PfMSP719)
where amino acid numbers correspond to the PF
3D7_1335100 protein sequence.
The ectodomains were expressed as soluble recombin-
ant proteins by transient transfection of HEK293E or
HEK293F cells with a C-terminal rat Cd4 domains 3 and
4 tag and with either a biotinylated C-terminal tag for
immobilization on streptavidin or a 6-His tag for purifi-
cation [19] and processed as described [20]. Where ap-
propriate, proteins were purified from transfected-
HEK293E cell culture supernatants on HisTrap HP col-
umns using an ÄKTAxpress instrument (GE Healthcare)
as described [21].
AVidity-based EXtracellular protein Interaction Screening
(AVEXIS)
AVEXIS assays were performed essentially as described
previously [20, 22]. Briefly, biotinylated ‘bait’ proteins
were immobilized in a well of a streptavidin-coated, 96-
well, microtitre plate at a concentration that saturated
the biotin binding capacity of the well. After a brief
wash, the bait arrays were probed with a highly avid
(pentamerized) β-lactamase-tagged ‘prey’ normalized to
previously determined activity levels [20, 22]. Prey
capture was quantified by measuring the absorbance of
the hydrolysis product of nitrocefin – a colorimetric
β-lactamase substrate – at 485 nm after one hour. Typ-
ically, a mean background absorbance value was calcu-
lated from negative controls, and subtracted from the
absorbance in each query well.
Where the anti-P-selectin antibody was used in blocking
experiments, immobilized P-selectin bait proteins were first
incubated with a range of concentrations of the CLB-
thromb/6 monoclonal antibody (Santa Cruz Biotechnology
Inc) for one hour, prior to incubation with the PfMSP7
prey. Where appropriate, both the full-length P-selectin bait
and PfMSP7 prey proteins were pre-incubated with a range
of EDTA concentrations (maximum 10 mM) for one hour
before use in AVEXIS.
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Human P-selectin was expressed on the surface of trans-
fected cells with its cytoplasmic region replaced by a
fluorescent marker by sub-cloning the entire P-selectin
ectodomain into a plasmid containing a transmembrane
domain and cytoplasmic eGFP, as described [23].
HEK293F cells were transiently transfected with this
plasmid and 24 hours later, ~1×106 cells were incubated
with 5 μg of purified FLAG-tagged pentameric prey
proteins for one hour at 4 °C. Cells were washed with
PBS and stained with 2 μg Cy3-conjugated anti-FLAG
M2 monoclonal antibody (Sigma-Aldrich). Cells were
washed and resuspended in 1 mL PBS and analysed on a
Becton-Dickinson LSR Fortessa flow cytometer. Where
appropriate, cells were pre-incubated with 10 μg mouse
monoclonal IgG1 antibodies for one hour at 4 °C prior
to addition of the FLAG-tagged prey. These antibodies
included the CLB-thromb/6 anti-P-selectin clone and
the OX102 anti-rat Cd200R clone (BioLegend).
Surface plasmon resonance
Surface plasmon resonance studies were performed
using a Biacore T100 instrument (GE Healthcare) at a
temperature of 37 °C in HBS buffer. Approximately 150
RU of a negative control bait (biotinylated rat Cd4 do-
mains 3 + 4) was immobilized in a streptavidin-coated
sensor chip in a reference flow cell and the binding re-
sponses subtracted from those in the query flow cell in
which an approximately molar equivalent of P-selectin
was immobilized. Purified PfMSP7 was buffer exchanged
in HBS and resolved by size exclusion chromatography
using a Superdex 2000 Increase 10/300 column (GE
Healthcare) prior to Biacore analysis. PfMSP7 formed
metastable oligomeric forms, the relative amounts of
which were preparation-dependent and did not correlate
simply with either protein concentration or storage time.
Increasing concentrations of purified PfMSP7 analyte
were injected over both flow cells at a flow rate of 100
μl/min and the chip surface regenerated at the end of
each cycle. Owing to the strength of this interaction,
regeneration of the chip surface required repeated
injections of 5 M NaCl. Responses of duplicate concen-
trations gave the same binding signals after a regener-
ation cycle, demonstrating that the regeneration solution
did not result in any loss of activity of the protein immo-
bilized on the chip.
P-selectin-Sialyl LewisX binding assays
A biotinylated derivative of SLeX (Glycotech) was clus-
tered around a streptavidin-alkaline phosphatase conju-
gate (Sigma) to create an avid enzyme-tagged SLeX
binding reagent (SLeX-AP). A 5:1 ratio of SLeX to
streptavidin-AP was found to be optimal to maximize
the P-selectin binding response. MonobiotinylatedP-selectin was immobilized on a streptavidin-coated
microtitre plate and probed with a dilution series of
SLeX-AP, incubated for one hour at room temperature
(approximately 22 °C). Plates were washed three times
with HBS containing 0.2 % Tween20 and then 100 μL of
1 mg/mL phosphatase substrate (4-Nitrophenyl phos-
phate disodium salt) was added to each well. SLeX-AP
binding was quantified by measuring the absorbance of
the hydrolysis products at 405 nm, 30 minutes after sub-
strate addition. To determine whether PfMSP7 could
block the interaction, immobilized P-selectin was incu-
bated with PfMSP7 pentamers for one hour prior to
washing before addition of 100 μL 0.1nM SLeX-AP.
Results
A systematic extracellular protein interaction screen
identified P-selectin as a receptor for PfMSP7
To identify potential Plasmodium ligands for P-selectin,
the entire ectodomains of 17 P. falciparum merozoite li-
gands [17] were screened for interactions against the en-
tire ectodomain of human P-selectin using AVEXIS.
AVEXIS is a systematic approach specifically developed
to identify low affinity extracellular interactions and
works by detecting direct binding events within libraries
of recombinant proteins expressed by mammalian cells
[22]. Briefly, ‘bait’ proteins, in this case P-selectin and
controls, are arrayed in microtitre plates and probed
with enzyme-tagged ‘preys’, in this case merozoite li-
gands, which have been purposefully clustered into pen-
tamers thereby increasing overall binding avidity to
detect even the most fleeting of interactions. Reprodu-
cible and robust binding signals were observed using the
PfMSP7 prey with the P-selectin bait (Fig. 1a). One sim-
ple and informative validation criteria for interactions
detected using the AVEXIS approach is to ask whether
the interaction is dependent on the bait-prey orientation
[22]. To test this, P-selectin was produced as a β-
lactamase-tagged prey and presented to both immobi-
lized PfMSP7 and control baits. Again, clear binding was
observed, although with a reproducibly lower signal,
possibly due to reduced prey activity caused by homo-
philic P-selectin interactions between prey molecules
(Fig. 1b); this prey ‘masking’ effect due to homophilic in-
teractions has been observed previously [22].
PfMSP7 is proteolytically processed and a C-terminal
fragment associates with and forms part of the MSP1
protein complex located on the merozoite surface
[16, 24]. To verify that the recombinant PfMSP7 prey
protein preparation was biologically active, its ability to
bind the PfMSP1 bait protein was demonstrated using
the AVEXIS assay as previously reported (panel a in
Additional file 1: Figure S1) [17]. Similarly, the recom-
binant P-selectin prey bound to a SLeX bait (panel a in
Additional file 1: Figure S1) and a P-selectin bait bound
Fig. 1 Systematic extracellular protein interaction screening by AVEXIS identified PfMSP7 as a ligand for human P-selectin. a The entire ectodomains of
the 17 named P. falciparum merozoite proteins were screened as highly avid β-lactamase-tagged prey proteins against P-selectin bait using the AVEXIS
method. Prey binding was quantified by β-lactamase hydrolysis of a colorimetric substrate at 485 nm. P-selectin bound clearly and specifically to
PfMSP7. Positive (+) represents mean value for total capture of all preys with an anti-prey bait antibody. b PfMSP7 and P-selectin prey proteins were
screened against PfMSP7 and P-selectin bait proteins as well as an OX68 positive control bait (+) and a rat Cd4 negative control bait (−) by AVEXIS.
Interactions were detected in both bait:prey orientations. c An anti-P-selectin mAb blocked the interaction between P-selectin bait and PfMSP7 prey in
a dose-dependent manner relative to an anti-Cd4 mAb control, which bound to the tag region of the P-selectin protein, in an AVEXIS assay. Bars in (b)
and (c) represent means ± SD, n = 3. Representative experiment of more than three independent experiments are shown
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in Additional file 1: Figure S1), again confirming the bio-
logical activity of the recombinant P-selectin protein. To
further confirm the specificity of the interaction, a
monoclonal antibody to P-selectin was used to block the
interaction in a dose-dependent manner (Fig. 1c). The
epitope of the anti-P-selectin monoclonal antibody CLB-
thromb/6, which blocked the P-selectin-MSP7 inter-
action, is located between the N-terminal C-type lectin
domain and EGF-like domain of P-selectin [25]. Be-
cause the SLeX binding properties of P-selectin’s C-
type lectin domain are dependent on calcium ions, the
necessity of calcium for the interaction with PfMSP7
was investigated. A concentration series of the divalent
cation chelator EDTA was used to demonstrate that
approximately 30 mM EDTA was sufficient to prevent
the interaction from occurring (panel c in Additional
file 1: Figure S1), which is in good agreement with
the concentration that was previously used to block
other P-selectin-binding interactions [26]. Together,
these data identify PfMSP7 as a possible ligand for
P-selectin.
PfMSP7 specifically binds P-selectin at the surface of cells
While the use of recombinant proteins in reductionist
in vitro assays allows important experimental control over
binding parameters, it does not satisfactorily replicate the
complex environment of cell surfaces in which the inter-
action would normally occur. To replicate the elements of
this environment, a P-selectin expression plasmid was
constructed in which the cytoplasmic region was replaced
with an eGFP reporter protein and then displayed at the
surface of human cells by transiently transfecting the
HEK293F cell line. Cells transfected with this constructwere incubated with a pentamerized FLAG-tagged
PfMSP7 prey protein and binding quantitated with an
anti-FLAG fluorescent secondary antibody using flow
cytometry relative to a control prey (Fig. 2a). A clear
double-positive population was observed demonstrating
that P-selectin-expressing (GFP-positive) cells interacted
with the PfMSP7 FLAG-tagged prey (Fig. 2b). Within the
sample of transfected cells used in each staining reaction,
the level of PfMSP7 binding was proportional to the P-
selectin-GFP expression level, and, importantly, the
untransfected (GFP-negative) cells within the population
did not bind PfMSP7 (Fig. 2b). The P-selectin dependency
of PfMSP7 binding was further established by preventing
binding by first pre-incubating the transfected cells with
the anti-P-selectin antibody (Fig. 2c). These data provide
additional evidence that MSP7 and P-selectin specifically
interact.
PfMSP7 forms multimers and directly interacts with
P-selectin with high avidity
To demonstrate that P-selectin and PfMSP7 interact dir-
ectly and to determine the biophysical binding parame-
ters of the interaction, surface plasmon resonance (SPR)
was used. The full length PfMSP7 protein was expressed
as a recombinant protein, purified and analysed by size
exclusion chromatography (SEC). Multiple preparations
of purified PfMSP7 protein repeatedly resolved as a
heterogenous polydisperse mixture of species, typically
containing a single predominant peak consistent with
the formation of higher-order oligomers, but with vary-
ing amounts of slower-eluting smaller forms of lower
molecular mass, which were preparation-dependent,
suggesting that full length PfMSP7 forms metastable
oligomers in solution (Fig. 3a). Multimeric assemblies of
Fig. 2 PfMSP7 interacted with P-selectin at the surface of cells. a Schematic representing the experimental design, whereby recombinant,
pentameric PfMSP7 proteins interact with eGFP-tagged P-selectin at the surface of transfected cells. b The interaction of P-selectin-eGFP
transfected cells with FLAG-tagged pentameric PfMSP7 was detected by flow cytometry. Pre-incubation of cells with anti-Cd200R negative
control mAb did not impair interaction detection. c P-selectin-GFP transfected cells incubated with CLB-thromb/6 anti P-selectin mAb prior to
incubation with FLAG-tagged pentameric PfMSP7 could not replicate this interaction observed in (b)
Perrin et al. Malaria Journal  (2015) 14:238 Page 5 of 9parasite proteins are known to be important for their
critical interactions with host proteins [27], and similar
oligomerization behaviour to that reported here has
been observed for the Plasmodium surface proteins
PfMSP2 and PfMSP3 [28–31].
After resolution by SEC, serial dilutions of the main spe-
cies of purified PfMSP7 were injected over P-selectin bait
immobilized on the surface of an SPR chip. Clear binding
responses were observed, demonstrating that the two pro-
teins interacted directly (Fig. 3b). As expected, given the
oligomeric state of PfMSP7, the shape of the binding
curves indicated complex multivalent binding behaviour
which did not fit well to a simple 1:1 binding model
(Fig. 3b). A rapid initial binding was followed by much
slower association, which did not achieve equilibrium over
the course of the injection phase which precluded the cal-
culation of an equilibrium dissociation constant. TheFig. 3 Full length PfMSP7 forms multimers and directly interacts with P-sel
was resolved by size-exclusion chromatography and eluted as a polydisper
though some elution profiles showed additional peaks at higher elution vo
dilution series of the major peak of resolved PfMSP7 was sequentially injec
SPR responses upon 20 s injections of the indicated concentrations of purislows dissociation of the two proteins during the wash-out
phase shows that the binding is highly avid, which is typ-
ical of a higher affinity interaction between a secreted pro-
tein and a membrane-tethered receptor.
PfMSP7’s interaction site is located within the
SLeX-binding C-type lectin and EGF domains of P-selectin
To further characterize the interaction, the regions on
both P-selectin and PfMSP7 responsible for binding
were identified. P-selectin consists of an N-terminal C-
type lectin (CTL) domain that forms the calcium-
dependent SLeX binding site followed by an epidermal
growth factor (EGF) domain, and nine short consensus
repeat (SCR) domains (Fig. 4a). A panel of structure-
guided C-terminally-truncated P-selectin bait proteins
was expressed and screened against a PfMSP7 prey
using the AVEXIS assay (Fig. 4a). A fragment consistingectin with high avidity. a Purified recombinant full-length PfMSP7
se peak. This was typical of more than ten independent preparations,
lumes. b Analysis of the PfMSP7/P-selectin interaction by SPR. A
ted over P-selectin immobilized on a streptavidin-coated sensor chip.
fied PfMSP7 analyte over P-selectin bait
Fig. 4 The PfMSP7 interaction site is located within the C-type lectin and EGF domains of P-selectin. a A schematic showing the extent of the six
P-selectin bait truncations that were expressed and then screened for binding to a full-length PfMSP7 prey using the AVEXIS assay. The shortest regions
that retained PfMSP7 binding encompassed both the CTL and EGF domains. b P-selectin bait was screened against PfMSP7 fragment prey proteins by
AVEXIS. Schematic shows the regions of the PfMSP7 proteins used in this assay, alongside the scheme of PfMSP7 processing described in the text. Bars
represent mean + SD n = 3. Representative experiments of two independent experiments are shown. In each experiment the positive controls (+) were
PfMSP7 preys screened against OX68 bait and negative controls (−) were PfMSP7 preys screened against the Cd4 tag bait
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PfMSP7 indistinguishably from the entire P-selectin
ectodomain, demonstrating that the PfMSP7 binding
site was located in the SLeX-binding N-terminal region
of P-selectin. To further resolve the binding region to
either the CTL or EGF domains, both domains were
expressed individually; however, both domains were
minimally required to interact with full-length PfMSP7
suggesting that the binding site spans both domains, or
there is a structural requirement that both domains are
functionally expressed as a discrete unit (Fig. 4a).
PfMSP7 is proteolytically processed within the merozo-
ite, being initially cleaved into two major forms: a
20 kDa N-terminal fragment that can be detected within
the parasitophorous vacuole [32], and a larger C-terminal
fragment which is further processed to leave a 22 kDa
fragment (PfMSP722) that can form part of the MSP1
complex, a major component of the merozoite surface. In
most strains of P. falciparum, PfMSP722 can be cleaved
again at the surface of the merozoite to leave PfMSP719 in
the MSP1 complex [24]. To determine which part of
PfMSP7 bound P-selectin, prey proteins corresponding to
PfMSP719, PfMSP722 and the N-terminal 20 kDa region
(referred to hereafter as PfMSP7-N) were expressed and
tested for binding to P-selectin by AVEXIS. PfMSP7-N -
the portion that is not part of the MSP1 complex on the
merozoite surface - interacted robustly with P-selectin; the
PfMSP719 and PfMSP722 prey did not interact (Fig. 4b).
This is a particularly interesting result, as no function has
previously been identified for the N-terminal fragments of
the PfMSP7 precursor protein. As expected, the PfMSP719
and PfMSP722 prey interacted with PfMSP1, as did
PfMSP7-N, which is consistent with the finding that theimmature PfMSP1 and PfMSP7 proteins associate prior to
processing [24], and also suggests that there may be mul-
tiple binding sites for PfMSP7 on PfMSP1.
PfMSP7 pentamers block the interaction between
P-selectin and SLeX
The finding that PfMSP7 interacted with the CTL do-
main of P-selectin suggested the possibility that it could
affect the binding of its endogenous ligand, SLeX, and
thereby prevent the recruitment of leukocytes to in-
flamed endothelium. To determine whether PfMSP7
could block the interaction between P-selectin and
SLeX, a dilution series of purified pentameric PfMSP7
was added to the P-selectin-SLeX binding assay used
previously (panel b in Additional file 1: Figure S1). This
showed that PfMSP7 could inhibit SLeX binding in a
concentration-dependent manner (Fig. 5). These data,
combined with the information from the domain map-
ping on P-selectin, demonstrate that PfMSP7 can com-
pete with SLeX -containing ligands for P-selectin
binding, and could therefore disrupt the normal pro-
adhesive and pro-inflammatory functions of P-selectin.The MSP7-P-selectin interaction is conserved within
paralogues and between orthologues
MSP7 is part of a paralogous gene family found in all se-
quenced Plasmodium spp. genomes. PfMSP7 and at least
five MSP7-related genes are located in tandem arrays on
chromosome 12 of P. falciparum [32, 33]. These genes have
a similar structure and organization, indicating that mem-
bers of this family have arisen through gene duplication,
although there is very little protein sequence conservation
Fig. 5 PfMSP7 can block the interaction between P-selectin and its glycan
ligand Sialyl-LewisX. P-selectin bait was immobilized and pre-incubated
with the indicated concentrations of the PfMSP7 pentamer before
addition of an avid alkaline-phosphatase-conjugated SLeX binding reagent.
PfMSP7 pentamers blocked SLeX binding to immobilized P-selectin. Data
points represent mean± SD, n= 3; a representative experiment from two
independent experiments is shown
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binding is a conserved function within PfMSP7 paralo-
gues, the full length sequences of all five MSP7-related
proteins (MSRPs) from P. falciparum were expressed as
prey proteins and tested for their ability to bind P-selectin
bait by AVEXIS. Of the five proteins, binding was detected
between P-selectin and both PfMSRP2 and PfMSRP5
(Fig. 6a). To determine whether the interaction is
conserved between other Plasmodium species that infect
humans, three of the approximately 11 MSP7-like proteins
encoded within the Plasmodium vivax genome were
expressed as prey proteins. Of these, clear binding was
observed with PVX_082675 (PvMSP7-6) (Fig. 6b). Finally,
recombinant Plasmodium berghei MSP7s were used to
determine whether this potential immunomodulatoryFig. 6 P-selectin binding is conserved within the wider MSP7 family across
AVEXIS were used to determine the conservation of binding within the MS
P. berghei (c). a P-selectin bound to PfMSRP2 and 5, but not PfMSRP1, 3 or
but not PvMSP7-1 or −9. P. vivax MSP7s are labelled according to their arra
9 = PVX_082655. c Both PbMSRP1 and 2 bound both human and mouse P
experiment from at least two independent experiments is shown in each c
screened against OX68 bait and negative controls (−) were PfMSP7 preys sinteraction was a conserved feature of Plasmodium infec-
tions in other mammalian species. Prey plasmids for all
three MSP7-like genes from the rodent parasite Plasmo-
dium berghei were designed, and although full length pro-
teins for both PbMSRP1 and PbMSRP2 were expressed,
repeated attempts failed to yield sufficient protein for
PbMSP7. Again using AVEXIS, binding was detected
between PbMSRP1 and PbMSRP2 and the mouse
P-selectin orthologue (Fig. 6c). The conservation of bind-
ing to P-selectin within the wider MSP7 family across dif-
ferent Plasmodium species suggests that this interaction
plays an important immunoregulatory role during Plasmo-
dium infections of mammalian hosts.
Discussion
Here, the identification and characterization of interac-
tions occurring between human P-selectin and Plasmo-
dium MSP7 proteins are described for the first time. Prior
to this work, much of the existing knowledge about
PfMSP7 pointed to a role in erythrocyte invasion based on
the original observation that a processed C-terminal frag-
ment of MSP7 co-purified and directly interacted with the
major merozoite surface protein, MSP1 [16, 24]. Consist-
ent with this, PfMSP7-deficient parasites exhibited subtle
(~30 %) reductions in the ability of the parasites to invade
human erythrocytes in vitro [15], and antibodies raised
against PfMSP7 have also been shown to impair invasion
[34]. Similarly, MSP7-deficient P. berghei parasites are
growth-attenuated compared to their wild-type counter-
parts in rodent models of infection [14, 35–37]. Interest-
ingly, a proteomic analysis of P. falciparum blood-stage
parasites selected to invade erythrocytes independently of
host sialic acid demonstrated a significant up-regulation
of PfMSP7, suggesting varying levels of PfMSP7 may
modulate erythrocyte recognition [38].
However, it is likely that MSP7 proteins also perform
additional roles that do not necessarily relate to erythrocytedifferent Plasmodium species. P-selectin-MSP7 binding assays using
P7 orthologues and paralogues of P. falciparum (a), P. vivax (b), and
4. b Detectable P-selectin binding was observed with PvMSP7-6,
ngement on chromosome: 1 = PVX_082700, 6 = PVX_082675, and
-selectin baits. Bars represent mean + SD, n =3. A representative
ase. In each experiment the positive controls (+) were PfMSP7 preys
creened against the Cd4 tag bait
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ciparum parasites, yet there is little evidence to suggest that
any of the MSRP proteins can substitute for PfMSP7’s role
in the MSP1 complex [39]. Evidence from rodent infections
with ΔPbMSP7 parasites indicates that PbMSP7 may have
an immunomodulatory function; ΔPbMSP7 parasites, com-
pared to their wild-type counterparts, were substantially
less deadly to their hosts, and ΔPbMSP7 parasites induced
much less cerebral pathology in ECM-susceptible mice, in a
manner that could not be entirely attributed to reduced
parasitaemia or anaemia [35, 36]. Differences in splenic
clearance and induction of CD8+ T cell population expan-
sion are also observed between wild-type and ΔPbMSP7
parasite infections [37].
The discovery that the N-terminal region of PfMSP7 is a
ligand for the host receptor P-selectin - a protein that has
well documented roles in leukocyte recruitment to sites of
inflamed endothelium - suggests a new functional role for
PfMSP7 that is distinct from invasion. This conclusion is
supported both by the absence of P-selectin from human
erythrocytes [40] and because the N-terminal region of
PfMSP7, which has been shown here to interact with P-
selectin, has not been detected on the merozoite surface,
indicating that the different fragments of PfMSP7 have
separate biological roles. The suggestion that the role of
MSP7-family proteins is not limited to promoting erythro-
cyte invasion is further supported by evidence that many
MSP7-family proteins are secreted, rather than being
localized at the merozoite surface; for example, both
PfMSRP5 [33] and the N-terminus of PfMSP7 [32], when
transgenically fused with GFP, are located within the
parasitophorous vacuole (PV), and the solubility of
PfMSRP2 in cultured parasites suggests that it is also
exported from the parasite into the PV [39]. It is there-
fore likely that MSP7-family proteins and their proc-
essed fragments are released into the host bloodstream
upon schizont rupture, so that they are able to directly
interact with host proteins free in the blood or those
displayed on blood cells or vascular endothelium.
Having taken the view that MSP7-P-selectin interactions
are unlikely to be involved in erythrocyte invasion, a model
can be suggested whereby MSP7 binding to P-selectin acts
to limit inflammatory processes and therefore impacts para-
site, and possibly host, survival. Such a role could help to
provide a molecular basis for the reported delay in death in
ΔPbMSP7 parasitized, ECM-resistant mice, compared to
those infected with wild-type parasites; by deploying MSP7
proteins to block the interaction between leukocytes and
the endothelium, Plasmodium parasites could potentially
dampen the production of pro-inflammatory cytokines and
phagocytic activity by leukocytes [41], thus aiding parasite
survival. The in vitro evidence that PfMSP7 is capable of
blocking the interaction P-selectin makes with leukocyte li-
gands indicates that this is theoretically possible, althoughin vivo it would undoubtedly be part of a much more com-
plex set of immunomodulatory mechanisms employed by
the Plasmodium parasite.
Given the complementary evidence that P-selectin-
deficient mice do not develop cerebral malaria [6] and that
ECM pathology is limited in susceptible mice infected with
ΔPbMSP7 parasites [36], it is tempting to speculate that the
interaction between P-selectin and MSP7 exacerbates the
pathological processes involved in the development of
cerebral malaria. This could conceivably be an indirect con-
sequence of MSP7 proteins interacting with soluble as op-
posed to membrane-bound P-selectin, impairing the ability
of free P-selectin to limit inflammatory interactions and thus
promoting systemic inflammation.Conclusion
These results demonstrate a novel interaction between a
human cell surface protein and a family of Plasmodium
proteins; since this interaction appears to have been evolu-
tionarily conserved in a range of parasite species, this
interaction may be beneficial to the parasite, allowing it to
modulate the host’s response to infection. If an impair-
ment of the capacity of MSP7 proteins to bind P-selectin
is found to underlie the defects in immune evasion and le-
thality seen in ΔMSP7 P. berghei parasites, then the poten-
tial to block this interaction from occurring in vivo
provides a new target for therapeutic interventions that
could mitigate illness and death from malaria.Additional file
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